Listen to the article
Indonesian health officials have dispelled widespread misinformation claiming that HPV vaccinations for children are experimental and dangerous, reaffirming the vaccine’s established safety record and crucial role in cancer prevention.
False claims circulated on social media in February 2026 suggested that Indonesia was using children as “guinea pigs” by planning to administer HPV vaccines to 11-year-old boys starting in 2027. The misleading content included a screenshot from a legitimate Kompas.com news article about the vaccination plans, paired with an unrelated video of a man protesting vaccines.
Fact-checkers at Tempo investigated the allegations and found them to be entirely unfounded. Their investigation revealed that the protest video dated back to January 2022 and showed a demonstration against COVID-19 vaccine mandates at the Ministry of Health—completely unrelated to HPV vaccination efforts.
Epidemiologist Dicky Budiman of Griffith University explained to Tempo that the HPV vaccine underwent rigorous development and testing procedures before receiving approval from global health authorities.
“The first HPV vaccine was approved 20 years ago, in 2006, by the World Health Organization, the European Medicine Agency, and the United States Food and Drug Administration,” Budiman stated. “This means this vaccine is suitable and safe for global use. It is no longer an experimental product.”
More than 125 countries have incorporated the HPV vaccine into their national immunization programs, with research demonstrating significant reductions in HPV infections, genital warts, precancerous lesions, and cervical cancer cases in young adults.
Arif Nur Muhammad Ansori, a virologist from Airlangga University, emphasized that administering the vaccine to children aged 9-13 is strategically timed to provide maximum protection before potential exposure to the virus. Immunogenicity studies indicate that children in this age range develop stronger, more stable immune responses compared to adults, allowing for more effective long-term protection against cervical cancer with smaller vaccine doses.
“This effort is a globally proven preventive strategy to break the chain of Human Papillomavirus transmission early,” Ansori noted.
The HPV vaccine’s development traces back to the 1990s in Australia. The initial 2006 vaccine targeted four major HPV types, while a 2014 version expanded coverage to protect against additional cancer-causing HPV variants.
Clinical evidence strongly supports the vaccine’s effectiveness. Large randomized trials have shown that early vaccination can reduce the risk of serious cervical cell changes by up to 99 percent for the HPV types most commonly associated with cervical cancer.
The United Kingdom has reported particularly impressive results, with young people vaccinated through school programs showing approximately 87 percent lower cervical cancer rates compared to unvaccinated older groups. Similar declines have been documented in other countries with high vaccination rates.
Despite these successes, HPV vaccination rates remain low across many African and Southeast Asian nations. Research by Kate T. Simms and colleagues projects that achieving 80-100 percent vaccination coverage for both boys and girls, along with adult vaccination programs, could prevent nearly 50 million cases of cervical cancer by 2100.
Indonesia’s plans to expand HPV vaccination to boys represents an important public health initiative aligned with global best practices, not an experimental program as falsely claimed. The initiative aims to enhance protection against HPV transmission, which causes cervical cancer—a disease that continues to affect thousands of Indonesian women annually.
Health officials urge the public to seek information about vaccines from credible medical sources rather than unverified social media claims, emphasizing that widespread vaccination remains one of the most effective tools for reducing cancer burden worldwide.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.
10 Comments
This fact check is a good reminder that we need to be vigilant about verifying claims, especially when it comes to important public health issues like vaccines. Relying on credible sources and expert guidance is key.
Agreed. Spreading misinformation about vaccines can have serious consequences, so it’s crucial that we counter false narratives with factual, scientifically-sound information.
The HPV vaccine has been extensively studied and proven safe and effective. It’s concerning to see false claims circulating that could discourage people from getting this important preventive measure. Fact-checking efforts like this are essential.
Absolutely. Vaccines are one of the most successful public health interventions, and it’s vital that we address misinformation to ensure people can make informed decisions about their health.
Vaccines are an important public health tool, and it’s concerning to see the spread of misinformation. I appreciate this fact check, which helps clarify the established safety record of the HPV vaccine.
Yes, the HPV vaccine has proven to be safe and effective in preventing certain types of cancer. It’s crucial that health authorities continue to provide accurate, evidence-based information to the public.
I’m glad health officials are proactively addressing these false claims about the HPV vaccine. It’s crucial to rely on scientific evidence and expert guidance when it comes to public health issues like this.
Absolutely. Vaccines have saved millions of lives, and it’s concerning to see misinformation spread about their safety. Fact-checking and transparency are essential to combat these harmful narratives.
Interesting fact check on the HPV vaccine. It’s important to address misinformation and ensure the public has accurate information about vaccine safety and efficacy. Vaccines play a crucial role in disease prevention and public health.
Agree, vaccines undergo rigorous testing and approval processes to ensure they are safe and effective. Spreading unfounded claims can undermine public trust in important public health measures.